Siemens Showcases Advanced Ultrasound Solutions

Siemens HealthcareAt the European Congress of Radiology (ECR) 2010 in Vienna, Siemens Healthcare presented its innovative ultrasound solutions. The highlight this year was the new release of its premium Acuson S2000 ultrasound system featuring significant advancements in ARFI technology (Acoustic Radiation Force Imaging) for the detection and quantification of tissue. Combined with a 3D breast volume scanner (ABVS), the Acuson S2000 is suited particularly for breast cancer diagnosis in women with dense breast tissue. In addition, Siemens introduced its latest mid-range ultrasound system, the Acuson X300 Premium Edition (PE) for routine clinical examinations. Thanks to ever-improving image acquisition, physicians have much greater diagnostic confidence with shorter examination times.

The latest version of the Acuson S2000 ultrasound system Release 2.0 from Siemens contains improved implementations of the ARFI technology. This method supports the physician in detecting and quantifying tissue. Using the two ARFI software solutions "Virtual Touch Tissue Imaging" and "Virtual Touch Tissue Quantification", the physician detects and measures the strain properties or stiffness of tissue, which may be correlated with pathology. These leading-edge solutions redefine the use of ultrasound in the diagnosis, treatment, and therapy of diseases affecting areas of the body that are difficult to examine with physical palpation, for example the liver. Virtual Touch Tissue Quantification currently is the only ARFI application in the industry to provide a numerical value related to tissue stiffness at a precise anatomical location. It is highly promising in identifying early stages of liver diseases causing cirrhosis.

New Acuson S2000 system with ABVS breast scanner
The new Acuson S2000 ultrasound system can also be used in diagnosing breast cancer: equipped with the world's first breast volume scanner, the physician or hospital personnel can acquire volume images of the female breast automatically using this innovative system. The breast scanner enables higher early detection rates of breast cancer particularly in women with dense breast tissue. The result is a user-independent and standardized examination. The uniquely designed transducer of the ABVS breast scanner generates volume images that for the first time show the coronal view of the breast - from the nipple to the breast wall - a view that previously could not be shown using conventional ultrasound.

Conventional hand held breast ultrasound is time-consuming and requires a high level of operator expertise, which is why ultrasound’s role in breast imaging has often been that of a secondary modality to look at a palpable mass identified on a mammogram. "The Automated Breast Volume Scanner (ABVS) has the potential to change that," said Dr. Norbert Gaus, CEO of the Ultrasound business unit at Siemens Healthcare. "The system automatically acquires full-field sonographic volumes of the breast for comprehensive review and diagnosis, streamlining workflow and reducing operator dependence and variability. At the same time, automated acquisition reduces scan time to approximately 10 minutes."

Acuson X300 Premium Edition all-round system for the clinical routine
The powerful Acuson X300 PE mid-range ultrasound system is a highly-developed all-round system especially suited to the requirements of the daily clinical routine. The compact system delivers exceptional performance across a wide variety of applications, from general imaging to cardiovascular and OB/GYN. The latest edition of the Acuson X300 offers contrast agent imaging, fourSight 4D imaging technology, and integrated stress echo. Anatomical M-mode, DTI Doppler Tissue Imaging technology, and TEE Imaging - including 3D imaging - complete the package.

Related news articles:

About Siemens Healthcare Sector
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2009 (to September 30), the Sector posted revenue of 11.9 billion euros and profit of around 1.5 billion euros. For further information please visit: www.siemens.com/healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...